1. Home
  2. COCP vs AEHL Comparison

COCP vs AEHL Comparison

Compare COCP & AEHL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • COCP
  • AEHL
  • Stock Information
  • Founded
  • COCP 2006
  • AEHL 1993
  • Country
  • COCP United States
  • AEHL China
  • Employees
  • COCP N/A
  • AEHL N/A
  • Industry
  • COCP Biotechnology: Pharmaceutical Preparations
  • AEHL Building Materials
  • Sector
  • COCP Health Care
  • AEHL Industrials
  • Exchange
  • COCP Nasdaq
  • AEHL Nasdaq
  • Market Cap
  • COCP 15.4M
  • AEHL 17.9M
  • IPO Year
  • COCP N/A
  • AEHL 2007
  • Fundamental
  • Price
  • COCP $1.37
  • AEHL $3.16
  • Analyst Decision
  • COCP Strong Buy
  • AEHL
  • Analyst Count
  • COCP 1
  • AEHL 0
  • Target Price
  • COCP $6.00
  • AEHL N/A
  • AVG Volume (30 Days)
  • COCP 4.3M
  • AEHL 1.8M
  • Earning Date
  • COCP 11-12-2025
  • AEHL 09-25-2025
  • Dividend Yield
  • COCP N/A
  • AEHL N/A
  • EPS Growth
  • COCP N/A
  • AEHL N/A
  • EPS
  • COCP N/A
  • AEHL N/A
  • Revenue
  • COCP N/A
  • AEHL $98,773,000.00
  • Revenue This Year
  • COCP N/A
  • AEHL N/A
  • Revenue Next Year
  • COCP N/A
  • AEHL N/A
  • P/E Ratio
  • COCP N/A
  • AEHL N/A
  • Revenue Growth
  • COCP N/A
  • AEHL 36.99
  • 52 Week Low
  • COCP $1.12
  • AEHL $1.79
  • 52 Week High
  • COCP $3.26
  • AEHL $44.80
  • Technical
  • Relative Strength Index (RSI)
  • COCP 38.00
  • AEHL 49.74
  • Support Level
  • COCP $1.31
  • AEHL N/A
  • Resistance Level
  • COCP $2.67
  • AEHL $8.42
  • Average True Range (ATR)
  • COCP 0.16
  • AEHL 0.69
  • MACD
  • COCP -0.01
  • AEHL -0.16
  • Stochastic Oscillator
  • COCP 4.42
  • AEHL 37.53

About COCP Cocrystal Pharma Inc.

Cocrystal Pharma Inc is a biotechnology company discovering and developing novel antiviral therapeutics that target the replication machinery of influenza viruses, hepatitis C viruses, and noroviruses. It employs structure-based technologies and Nobel Prize-winning expertise to create first and in-class antiviral drugs. It is developing CC-31244, an investigational, oral, broad-spectrum replication inhibitor called a non-nucleoside inhibitor (NNI).

About AEHL Antelope Enterprise Holdings Limited

Antelope Enterprise Holdings Ltd operates in two reportable operating segments: 1) business management consulting, information system technology consulting services including the sales of software use rights for digital data deposit platforms and asset management systems, and online social media platform development and consulting, and 2) natural gas power generation, which was in the initial development stage. The business of the Company is engaged in the PRC and U.S.

Share on Social Networks: